Influence of liver pathology on markers of postmortem brain tissue quality

Alcoholism: Clinical and Experimental Research

Volumn 36, Issue 1, 2012, Pages 55-60

  Sheedy, Donna ^a   Say, Meichien ^a   Stevens, Julia ^a,b   Harper, Clive G ^a   Kril, Jillian J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b SCHIZOPHRENIA RESEARCH INSTITUTE   (Australia)

Author keywords

Alcohol; Cirrhosis; Hepatic Encephalopathy; Postmortem Brain

Indexed keywords

ADULT; AGED; ALCOHOL ABUSE; ARTICLE; AUTOPSY; BRAIN TISSUE; CEREBELLUM; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; FATTY LIVER; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; HYPOXIC ISCHEMIC ENCEPHALOPATHY; LIVER CIRRHOSIS; LIVER DISEASE; MALE; PH; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ALCOHOLISM; BIOLOGICAL MARKERS; BRAIN; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; HUMANS; LIVER; LIVER CIRRHOSIS, ALCOHOLIC; LIVER DISEASES, ALCOHOLIC; MALE; MIDDLE AGED; POSTMORTEM CHANGES;

EID: 84855325844     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/j.1530-0277.2011.01580.x     Document Type: Article

References (37)

1. Atz M, Walsh D, Cartagena P, Li J, Evans S, Choudary P, Overman K, Stein R, Tomita H, Potkin S, Myers R, Watson SJ, Jones EG, Akil H, Bunney WEJr, Vawter MP (2007) Methodological considerations for gene expression profiling of human brain. J Neurosci Methods163:295-309.
2. Benarroch EE (2005) Neuron-astrocyte interactions: partnership for normal function and disease in the central nervous system. Mayo Clin Proc80:1326-1338.
3. Buesa C, Maes T, Subirada F, Barrachina M, Ferrer I (2004) DNA chip technology in brain banks: confronting a degrading world. J Neuropathol Exp Neurol63:1003-1014.
4. Butterworth RF (2009) Hepatic encephalopathy: a primary astrocytopathy, in Astrocytes in (Patho)physiology of the Nervous System (Parpura V, Haydon PG eds), pp 673-692. Springer, Boston, MA.
5. Butterworth RF (2010) Metal toxicity, liver disease and neurodegeneration. Neurotox Res18:100-105.
6. Chesler M (2003) Regulation and modulation of pH in the brain. Physiol Rev83:1183-1221.
7. Gee JR, Keller JN (2005) Astrocytes: regulation of brain homeostasis via apolipoprotein E. Int J Biochem Cell Biol37:1145-1150.
8. Harris J, Chimelli L, Kril JJ, Ray D (2008) Nutritional deficiencies, metabolic disorders and toxins affecting the nervous system, in Greenfield's Neuropathology (Love S, Louis DN, Ellison DW eds), pp 675-731. Edwards Arnold Ltd, London.
9. Harrison PJ, Heath PR, Eastwood SL, Burnet PW, McDonald B, Pearson RC (1995) The relative importance of premortem acidosis and postmortem interval for human brain gene expression studies: selective mRNA vulnerability and comparison with their encoded proteins. Neurosci Lett200:151-154.
10. Haussinger D, Gorg B (2010) Interaction of oxidative stress, astrocyte swelling and cerebral ammonia toxicity. Curr Opin Clin Nutr Metab Care13:87-92.
11. Horvath MC, Hurd YL, Rajs J, Keller E (2006) Variations in respiratory distress characterize the acute agonal period during heroin overdose death: relevance to postmortem mRNA studies. Brain Res Bull70:251-259.
12. Kingsbury AE, Foster OJ, Nisbet AP, Cairns N, Bray L, Eve DJ, Lees AJ, Marsden CD (1995) Tissue pH as an indicator of mRNA preservation in human post-mortem brain. Brain Res Mol Brain Res28:311-318.
13. Kril JJ, Flowers D, Butterworth RF (1997) Distinctive pattern of Bergmann glial pathology in human hepatic encephalopathy. Mol Chem Neuropathol31:279-287.
14. Li JZ, Vawter MP, Walsh DM, Tomita H, Evans SJ, Choudary PV, Lopez JF, Avelar A, Shokoohi V, Chung T, Mesarwi O, Jones EG, Watson SJ, Akil H, Bunney WEJr, Myers RM (2004) Systematic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions. Hum Mol Genet13:609-616.
15. Lizardi-Cervera J, Almeda P, Guevara L, Uribe M (2003) Hepatic encephalopathy: a review. Ann Hepatol2:122-130.
16. Magistretti PJ (2006) Neuron-glia metabolic coupling and plasticity. J Exp Biol209:2304-2311.
17. Magistretti PJ (2009) Role of glutamate in neuron-glia metabolic coupling. Am J Clin Nutr90:875S-880S.
18. Marquez-Aguirre AL, Canales-Aguirre AA, Gomez-Pinedo U, Galvez-Gastelum FJ (2010) Molecular aspects of hepatic encephalopathy. Neurologia25:239-247.
19. Matsuda-Matsumoto H, Iwazaki T, Kashem MA, Harper C, Matsumoto I (2007) Differential protein expression profiles in the hippocampus of human alcoholics. Neurochem Int51:370-376.
20. Mellergard P, Siesjo BK (1998) Cerebral energy metabolism and pH, in pH and Brain Function (Kaila K, Ransom B eds), pp 67-92. John Wiley and Sons Inc., New York.
21. Miguel-Hidalgo JJ, Wei J, Andrew M, Overholser JC, Jurjus G, Stockmeier CA, Rajkowska G (2002) Glia pathology in the prefrontal cortex in alcohol dependence with and without depressive symptoms. Biol Psychiatry52:1121-1133.
22. Miller CL, Diglisic S, Leister F, Webster M, Yolken RH (2004) Evaluating RNA status for RT-PCR in extracts of postmortem human brain tissue. BioTechniques36:628-633.
23. Monoranu CM, Apfelbacher M, Grunblatt E, Puppe B, Alafuzoff I, Ferrer I, Al-Saraj S, Keyvani K, Schmitt A, Falkai P, Schittenhelm J, Halliday G, Kril J, Harper C, McLean C, Riederer P, Roggendorf W (2009) pH measurement as quality control on human post mortem brain tissue: a study of the BrainNet Europe consortium. Neuropathol Appl Neurobiol35:329-337.
24. Mulligan SJ, MacVicar BA (2004) Calcium transients in astrocyte endfeet cause cerebrovascular constrictions. Nature431:195-199.
25. Oberheim NA, Takano T, Han X, He W, Lin JH, Wang F, Xu Q, Wyatt JD, Pilcher W, Ojemann JG, Ransom BR, Goldman SA, Nedergaard M (2009) Uniquely hominid features of adult human astrocytes. J Neurosci29:3276-3287.
26. Preece P, Cairns NJ (2003) Quantifying mRNA in postmortem human brain: influence of gender, age at death, postmortem interval, brain pH, agonal state and inter-lobe mRNA variance. Brain Res Mol Brain Res118:60-71.
27. Rintala J, Jaatinen P, Kiianmaa K, Riikonen J, Kemppainen O, Sarviharju M, Hervonen A (2001) Dose-dependent decrease in glial fibrillary acidic protein-immunoreactivity in rat cerebellum after lifelong ethanol consumption. Alcohol23:1-8.
28. Schroeder A, Mueller O, Stocker S, Salowsky R, Leiber M, Gassmann M, Lightfoot S, Menzel W, Granzow M, Ragg T (2006) The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol Biol7:3.
29. Sheedy D, Garrick T, Dedova I, Hunt C, Miller R, Sundqvist N, Harper C (2008) An Australian Brain Bank: a critical investment with a high return!Cell Tissue Bank9:205-216.
30. Stan AD, Ghose S, Gao XM, Roberts RC, Lewis-Amezcua K, Hatanpaa KJ, Tamminga CA (2006) Human postmortem tissue: what quality markers matter?Brain Res1123:1-11.
31. Takano T, Tian GF, Peng W, Lou N, Libionka W, Han X, Nedergaard M (2006) Astrocyte-mediated control of cerebral blood flow. Nat Neurosci9:260-267.
32. Tomita H, Vawter MP, Walsh DM, Evans SJ, Choudary PV, Li J, Overman KM, Atz ME, Myers RM, Jones EG, Watson SJ, Akil H, Bunney WEJr (2004) Effect of agonal and postmortem factors on gene expression profile: quality control in microarray analyses of postmortem human brain. Biol Psychiatry55:346-352.
33. Vawter MP, Tomita H, Meng F, Bolstad B, Li J, Evans S, Choudary P, Atz M, Shao L, Neal C, Walsh DM, Burmeister M, Speed T, Myers R, Jones EG, Watson SJ, Akil H, Bunney WE (2006) Mitochondrial-related gene expression changes are sensitive to agonal-pH state: implications for brain disorders. Mol Psychiatry11:615, 663-679.
34. Verkhratsky A, Parpura V (2010) Recent advances in (patho)physiology of astroglia. Acta Pharmacol Sin31:1044-1054.
35. Webster MJ (2006) Tissue preparation and banking. Prog Brain Res158:3-14.
36. Weis S, Llenos IC, Dulay JR, Elashoff M, Martinez-Murillo F, Miller CL (2007) Quality control for microarray analysis of human brain samples: the impact of postmortem factors, RNA characteristics, and histopathology. J Neurosci Methods165:198-209.
37. Xu J, Kochanel K, Sherry M, Betzalda T-V (2010) Deaths: final data for 2007. US Department of Health and Human Services, Hyattsville, MD, National Center for Health Statistics58:1-135.